Outcomes of Albumin Use in the Treatment of Acute Hepatorenal Disorders: A Single Center Experience
Journal of Renal and Hepatic Disorders · 2017
DOI: 10.15586/jrenhep.2017.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Renal and Hepatic Disorders, 2017. Verfasst von Krishna Pothugunta und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intravenous albumin is recommended for hepatorenal disorders (HRD), but individuals who do not recover renal function may be at a high risk for pulmonary edema. We reviewed outcomes by the amount of albumin infused in 93 patients not receiving dialysis at admission but being treated with intravenous albumin for acute HRD at our institution. Absence of renal recovery was defined as no decrease in serum creatinine and requirement of dialysis during hospitalization, and partial renal recovery was defined as a decrease in serum creatinine but not to prehospitalization levels. Associations of clinical factors including total albumin infused, presence of renal recovery, and oliguria with the development of pulmonary edema during hospitalization were determined using logistic regression. Of the 93 patients, 20 patients had complete renal recovery, 17 patients had partial renal recovery, and 56 patients showed no renal recovery. Most patients received 300–600 g of albumin. Overall, 47.3% of patients developed pulmonary edema (n=44), but the risk was 75% in patients with oliguria on presentation and no renal recovery versus 17% in those with no oliguria and complete renal recovery (P
Zitieren
APA
Pothugunta, K., Voora, S., Kramer, H. J., Bidani, A. K., & Vellanki, K. (2017). Outcomes of Albumin Use in the Treatment of Acute Hepatorenal Disorders: A Single Center Experience. Journal of Renal and Hepatic Disorders. https://doi.org/10.15586/jrenhep.2017.2
Vancouver
Pothugunta K, Voora S, Kramer HJ, Bidani AK, Vellanki K. Outcomes of Albumin Use in the Treatment of Acute Hepatorenal Disorders: A Single Center Experience. Journal of Renal and Hepatic Disorders. 2017. doi:10.15586/jrenhep.2017.2
BibTeX
@article{Pothugunta2017,
author = {Pothugunta, Krishna and Voora, Santhi and Kramer, Holly Joy and Bidani, Anil K and Vellanki, Kavitha},
title = {Outcomes of Albumin Use in the Treatment of Acute Hepatorenal Disorders: A Single Center Experience},
journal = {Journal of Renal and Hepatic Disorders},
year = {2017},
doi = {10.15586/jrenhep.2017.2}
}
EUVIMED